INSUBCONTINENT EXCLUSIVE:
business.But, the doctor-services provider closed up almost 40% on a somewhat ambitious price of $14 per share
It had raised $532.1 million during its time as a private company, with a fairly recent valuation of $1.71 billion
deeply minority recurring revenue and 30% revenue growth in 2019 atbest, as Alex noted on Extra Crunch Friday
work to improve medical care is laudable regardless of these questions (in fact, it won the Best Healthcare Startup Crunchie in 2013).Stay
this both as a startup investor and, through a separate part of his company, as an acquirer, and has kindly provided a detailed explainer on
of our category creation ideas pans out, and we succeed in winning a very targeted segment of the market, is there an opportunity for this
expected to help incumbents boost consumer-facing service quality, and new technologies cracking open more possibilities for companies of
my [Blossom] partner Louise was as well, I think what it has really shown to people is that you can take risk at the early stage and build
meaningful businesses from Europe
going to move to the valley and trying to build my teams because talent is so competitive and so expensive over there, I want to build in
beginning and early stages, and then going on to produce some really interesting things
decade (EC)True product-market fit is a minimum viable company (TC)Gauging email success, invite-only app launches and other growth tactics
(EC)All eyes are on the next liquidity event when it comes to space startups (TC)Essential advice for securing your small startup (EC)Adding
startup funding trendsUpdates on the on-demand warsThe latest in tech IPOsGet Startups Weekly in your inbox every Saturday morning, just
